About Dr Dayen Goodenowe

Dr. Dayan Goodenowe is a PhD neuroscientist, biochemist, synthetic organic chemist, inventor, and clinical research expert. In 1999, he invented and patented a revolutionary ion cyclotron resonance mass spectrometry technology that made it possible to monitor human biochemistry comprehensively for the first time in history.

Using this advanced technology, Dr. Goodenowe analyzed blood samples from tens of thousands of persons of all ages, of all races, and of multiple countries. The biochemistry of healthy persons was compared to persons suffering from disease. A diverse range of over 20 diseases, from autism to dementia and from colon cancer to heart disease, was studied. The biochemistry of young versus old and all-cause mortality was studied. This research led to his discovery that early mortality and each human disease has a biochemical prodrome.

These findings contributed to an extensive patent portfolio of diagnostic tests for the early detection and screening of diseases such as specific cancers (colon, pancreatic, ovarian, breast, lung, prostate, and many more), autism, multiple sclerosis, Parkinson’s, ALS, Alzheimer’s, dementia, bipolar disease, schizophrenia, unipolar depression, cardiovascular disease, and others. Dr. Goodenowe created the ProdromeSCAN™ blood test, which measures all of the key prodrome biomarkers and offers advanced laboratory test interpretation training for health practitioners.

The Science Behind PreCODE and ReCODE

The ProdromeScan™ is a lab-developed, comprehensive blood test crafted by Dr. Dayan Goodenowe and Prodrome Sciences. Backed by over 30 years of research and applied to more than 50,000 patients, it offers a detailed assessment of over 40 biomarkers spanning critical biochemical systems in the body. Unlike standard diagnostic tests, ProdromeScan™ focuses on health optimisation, revealing early warning signs—or prodromes—before disease manifests, thereby supporting proactive wellness strategies

Why It Matters: The ProdromeScan™ Advantage

A Holistic Health Snapshot
ProdromeScan™ offers a comprehensive biochemical overview that captures functional health long before disease onset, allowing users to “focus on getting the basics right” and build toward true vitality

Plasmalogen Focus
Plasmalogens, cell membrane lipids critical for neuroprotection, ageing, and cognitive health, are central to the test. Low levels have been linked with conditions like dementia, Parkinson’s, MS, and cognitive decline

Guided Health Optimisation
The test feeds directly into tailored interventions—diet, lifestyle, and supplementation—especially with Dr. Goodenowe’s plasmalogen precursor products (e.g., ProdromeNeuro™, ProdromeGlia™). These are selected based on the specific biomarker imbalances the test reveals

ProdromeScan™ – Biochemical Health Like No Other

The ProdromeScan™ is a comprehensive blood test developed by Dr. Dayan Goodenowe, providing a deep dive into over 40 critical biomarkers across lipid metabolism, inflammation, mitochondrial function, and more. It offers a proactive window into your health—highlighting early imbalances before conditions arise—and supports targeted, personalized interventions.

This isn’t just about diagnosing disease—it’s about optimizing vitality. Through repeated testing and guided supplementation, ProdromeScan™ empowers you to rebuild and maintain foundational health from the cellular level upward.

Dr. Dayan Goodenowe’s research on Multiple Sclerosis has identified stage-specific metabolic signatures that shed light on disease mechanisms and potential interventions. In a 2015 case-control study, he found that relapsing–remitting MS showed elevated gut-derived anti-inflammatory metabolites, while progressive forms were marked by mitochondrial stress and altered plasmalogen levels—suggesting these biomarkers could aid early detection and monitoring. Preclinical work further demonstrated that plasmalogen precursor supplementation can protect against demyelination and support remyelination, highlighting a promising therapeutic strategy.

Download the sample report

Training in Dr Goodenowe’s work

For practitioners wishing to find out more:

Testing via Colab Services Ltd

We are delighted to offer the incredible ProdromeScan testing. Systems supported by this test are related to fatigue/mitochondrial health, cholesterol changes, essential fat status and cognitive function through testing Phospholipids, Fatty acids, GTAs, Iron, Choline, Mito function, C-RP, Elongase 5, Peroxisomal function, cholesterol and kidney function.

What Does the ProdromeScan™ Measure?

The test evaluates a wide array of biomarkers and biosystem functions, including:

Our Test
Membrane integrity & lipid metabolism: Ethanolamine plasmalogens, phosphatidylethanolamines, phosphatidylcholines, sphingomyelins, ceramides, dietary fatty acids (omega-3, -6, -9, DHA, oleic acid), and fatty acid elongation
Peroxisomal & mitochondrial function, inflammation markers (like CRP), gut health indicators such as gastrointestinal tract acids (GTAs), cholesterol transport, homocysteine, urea, creatinine, oxidative stress
Organ and systemic profiles including kidney function, methyltransferase/choline system performance, and overall biochemical system sufficiencies

PR650 ProdromeScan
View The Test
PR651 PlasmaloganPlus
View The Test

View All Our Metabolism/Glycaemic Flexibility/Nutrient status tests

Latest

BioMetrix™ BioScan – A Whole-New Way to Know Your Biochemistry

The BioMetrix™ BioScan is Dr. Goodenowe’s cutting-edge mass spectrometry technology, offering a fingertip touch on your molecular health. By detecting early shifts in inflammation, metabolism, cognition, and more—often before symptoms arise—it transforms raw data into a road map for restoring function. Each scan includes a clear report, practitioner guidance, and a personalized plan to help you rebuild and maintain your body's optimal balance. Coming Soon!

Download Me (coming soon)

Sample Report: